Demethylase FTO inhibits the occurrence and development of triple-negative breast cancer by blocking m<sup>6</sup>A-dependent miR-17-5p maturation-induced ZBTB4 depletion
Author:
Publisher
China Science Publishing & Media Ltd.
Subject
General Medicine,Biochemistry,Biophysics,Molecular Biology
Link
https://engine.scichina.com/doi/pdf/209646615E154C5DA8CD15F416B90212
Reference52 articles.
1. Zheng X, Li W, Yi J, Liu J, Ren L, Zhu X, Liu S. EZH2 regulates expression of FOXC1 by mediating H3K27me3 in breast cancers. Acta Pharmacol Sin, 2021, 42: 1171-1179.
2. Agostinetto E, Losurdo A, Nader-Marta G, Santoro A, Punie K, Barroso R, Popovic L. Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer. Expert Opin Investal Drugs, 2022, 31: 567-591.
3. Yin L, Duan JJ, Bian XW, Yu S. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res, 2020, 22:
4. Won K‑, Spruck C. Triple‑negative breast cancer therapy: current and future perspectives (Review). Int J Oncol, 2020, 57: 1245-1261.
5. Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N, Hwang ES, Khan SA. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol, 2021, 39: 1485-1505.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3